Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Islets ; 14(1): 114-127, 2022 12 31.
Artigo em Inglês | MEDLINE | ID: mdl-35348048

RESUMO

The prevalence of diabetes is rapidly increasing. The current number of diagnosed cases is ~422 million, expected to reach ~640 million by 2040. Type 2 diabetes, which constitutes ~95% of the cases, is characterized by insulin resistance and a progressive loss of ß-cell function. Despite intense research efforts, no treatments are yet able to cure the disease or halt its progression. Since all existing animal models of type 2 diabetes have serious drawbacks, one is needed that represents the complete pathogenesis, is low cost and non-obese, and can be developed relatively quickly. The aim of this study was to evaluate a low-cost, non-obese model of type 2 diabetes engendered by administering a daily high dose of tacrolimus (an immunosuppressant) to Wistar rats for 4 weeks. The biochemical and antioxidant markers were measured at basal and after the 4-week tacrolimus treatment. At week 4, the values of these parameters closely resembled those observed in human type 2 diabetes, including fasting blood glucose at 141.5 mg/dL, blood glucose greater than 200 mg/dL at 120 min of the glucose tolerance test, blood glucose at varied levels in the insulin tolerance test, and elevated levels of cholesterol and triglyceride. The tacrolimus treatment produced hypoinsulinemia and sustained hyperglycemia, probably explained by the alteration found in pancreatic ß-cell function and morphology. This model should certainly be instrumental for evaluating possible type 2 diabetes treatments, and for designing new immunosuppressants that do not cause pancreatic damage, type 2 diabetes, or new-onset diabetes after transplantation (NODAT).


Assuntos
Diabetes Mellitus Tipo 2 , Tacrolimo , Animais , Glicemia , Diabetes Mellitus Tipo 2/tratamento farmacológico , Teste de Tolerância a Glucose , Ratos , Ratos Wistar , Tacrolimo/uso terapêutico
2.
Horm Metab Res ; 46(7): 499-504, 2014 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-24810472

RESUMO

We investigated whether oxidative damage and insulin polymerization at a systemic level are associated with the insulin resistance (IR) observed in obese subjects. We evaluated 3 groups (n=16/each) divided according to body mass index (BMI): Normal weight (NW) with a BMI of 18.5-24.9, obese 1 (O1) 30-34.9, and obese 3 (O3)>40 kg/m(2). IR and oxidative damage status of the groups were established by HOMA value and the analysis of biomarkers of oxidative stress in plasma. Insulin polymers in systemic circulation were detected using an antibody specific coupled to magnetic beads, which were incubated in plasma from the study groups. Analysis of magnetic beads by electrophoresis on polyacrylamide gel and silver stain assessed the presence of insulin polymers. The inhibition of polymers formation was studied by the presence of (-)-epicatechin. We demonstrated that O1 and O3 subjects with IR showed higher oxidative damage to their plasma lipids and proteins than NW subjects. This oxidative damage was associated with the presence of insulin polymers in the plasma of the O1 and O3 subjects. This polymer showed a high concentration of carbonyl groups by Western blot, suggesting the participation of oxidative damage in the generation of the polymer. The antioxidant (-)-epicatechin decreased the formation of the insulin polymer, indicating that the prevention of oxidative damage can inhibit insulin polymerization. Our study revealed an association between the presence of carbonyl stress, IR, and insulin polymer formation in obese subjects. This study also demonstrates that the antioxidant (-)-epicatechin inhibits insulin polymerization.


Assuntos
Biopolímeros/sangue , Catequina/farmacologia , Insulina/sangue , Obesidade/sangue , Carbonilação Proteica/efeitos dos fármacos , Adulto , Antioxidantes/metabolismo , Biomarcadores/sangue , Humanos , Estresse Oxidativo/efeitos dos fármacos , Polimerização/efeitos dos fármacos
3.
Rheumatol Int ; 33(9): 2261-7, 2013 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-23455630

RESUMO

To compare oxidative stress (OS) biomarkers and antioxidant capacity of plasma (ACP) between dcSSc (diffuse cutaneous systemic sclerosis) and healthy Mexicans and their possible relationship with autoantibodies, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and uric acid (UA). We included 28 dcSSc and 28 healthy individuals. Patients were grouped in early and late dcSSc and were excluded if they had infections, neoplasias, comorbidity, or antioxidant treatment. Lipoperoxidation products (malondialdehyde), protein oxidation products (carbonyls, dityrosines), ACP, CRP, ESR, and UA were investigated. Age was 47.5 ± 10 in dcSSc versus 48 ± 7 years in controls. In dcSSc, OS was higher and ACP was decreased versus controls (p < 0.001). OS was similar in early and late dcSSc. Anti-Scl-70 (anti-topoisomerase I) was associated with a higher OS (p < 0.05). Eight dcSSc patients had hyperuricemia (28.5 %). A significant correlation between UA and malondialdehyde, dityrosines and carbonyls levels (r = 0.52, r = 0.78 and r = 0.69, p < 0.01) respectively, was found in dcSSc group. A high level of ESR was present in 71 % and CRP in 40 % of dcSSc patients. Mexican dcSSc patients had elevated lipid/protein OS with respect to healthy controls. These OS biomarkers have direct correlation with UA levels. ESR and CRP were elevated in a great number of dcSSc patients. These biochemical markers suggest that dcSSc patients have a continuous stimulus for endothelial dysfunction and accelerated atherogenesis.


Assuntos
Estresse Oxidativo , Esclerodermia Difusa/metabolismo , Adulto , Biomarcadores , Sedimentação Sanguínea , Proteína C-Reativa/análise , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Esclerodermia Difusa/complicações , Ácido Úrico/sangue
4.
J Hum Hypertens ; 27(6): 355-61, 2013 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-23223087

RESUMO

Pregnancy is a state of vasodilation mediated by nitric oxide (NO). This vasodilation is impaired in women with preeclampsia, and an alteration in the L-arginine-NO pathway may be a causal factor. The production of NO and arginase activity were investigated in plasma and human umbilical vein endothelial cells (HUVECs) from women with preeclampsia, which were associated with arginase II, eNOS, caveolin, angiotensin 1 and 2 receptor expression (AT1R and AT2R, respectively). The effect of (-)-epicatechin on arginase activity and production of anion superoxide in HUVEC also were investigated. Healthy volunteer non-pregnant (HV), normal pregnant (NP) and preeclamptic (PE) women were recruited for this study. Higher values of nitrite/nitrate (NO(2)/NO(3)) were detected in the plasma from PE women as opposed to HV and NP. Lower arginase activity in PE versus HV or NP women was observed. HUVECs from PE women showed lower values of NO(2)/NO(3), higher activity of arginase and higher expression of AT(1)R and AT(2)R than HUVECS from NP women. Interestingly, arginase activity was associated with AT(2)R stimulation; indeed this activity and the high NADPH (nicotinamide adenine dinucleotide phosphate) oxidase activity in HUVECs from PE women can uncouple the production or inactivation of NO. However, we demonstrated that (-)-epicatechin could lead to a decrease in the activity of both enzymes.


Assuntos
Arginina/metabolismo , Catequina/farmacologia , Células Endoteliais da Veia Umbilical Humana/efeitos dos fármacos , Células Endoteliais da Veia Umbilical Humana/metabolismo , Óxido Nítrico/metabolismo , Pré-Eclâmpsia/metabolismo , Receptor Tipo 2 de Angiotensina/fisiologia , Adulto , Células Cultivadas , Feminino , Humanos , Redes e Vias Metabólicas , Gravidez , Adulto Jovem
5.
Horm Metab Res ; 43(11): 748-53, 2011 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-22009368

RESUMO

Obesity and its associated disorders constitute a growing epidemic across the world. Numerous studies have demonstrated the presence of systemic oxidative stress in patients with obesity. In this study, we show the effects of oxidative stress present in the blood from obese patients on recombinant human insulin. Insulin was incubated with whole blood (WB) from overweight subjects (OW), obese 1 patients (O1), or normal weight volunteers (NW) (n=16 for each group). Whole blood from OW and O1, unlike WB from NW, increased the carbonyl content of insulin; however, only whole blood from O1 patients increased the amount of formazan present in the hormone. Interestingly, the incubation of insulin with WB from O1 provoked a decrease in the hypoglycemic activity of the hormone (18%), an effect due to insulin polymerization. In addition, we showed that the formation of the insulin polymer generated the formation of new epitopes and the development of a new immunogenicity. These observations show that oxidative stress present in the WB of O1 patients can result in abolition of the biological activity of insulin and contribute to the development of an immune response to the hormone.


Assuntos
Hipoglicemiantes/química , Resistência à Insulina , Insulina Regular Humana/química , Obesidade/sangue , Estresse Oxidativo , Adulto , Animais , Reações Antígeno-Anticorpo , Biomarcadores/sangue , Índice de Massa Corporal , Feminino , Formazans/análise , Humanos , Hipoglicemiantes/isolamento & purificação , Hipoglicemiantes/farmacologia , Insulina Regular Humana/isolamento & purificação , Insulina Regular Humana/farmacologia , Camundongos , Obesidade/imunologia , Sobrepeso/sangue , Sobrepeso/imunologia , Oxirredução , Polimerização , Carbonilação Proteica , Proteínas Recombinantes/química , Adulto Jovem
6.
Mol Cell Biochem ; 216(1-2): 9-19, 2001 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-11216869

RESUMO

Regulation of catalase (CAT) expression, a major antioxidant enzyme that detoxifies H2O2, is very complex. Garlic is effective to prevent or ameliorate oxidative stress probably through its intrinsic antioxidant properties and/or to its ability to modify antioxidant enzyme expression. In this paper we studied the effect of a 2% garlic diet on the renal and hepatic CAT expression (mRNA levels, and enzyme activity, content, synthesis, and degradation). The study was made 2 weeks after feeding rats with a 2% garlic diet. CAT activity and content were measured by a spectrophotometric method and Western blot, respectively. CAT mRNA levels and CAT synthesis (k(s)) and degradation (kD) in vivo were measured by Northern blot and kinetic of reappearance of CAT activity after aminotriazole injection, respectively. Garlic-treatment decreased CAT activity and content, and CAT mRNA levels were unchanged in both tissues. k(s) decreased and kD remained unchanged in kidney and liver. The decrease in k(s) without changes in kD and CAT mRNA levels could explain the low CAT expression in garlic-fed rats. In vivo H2O2 generation in kidney and liver was markedly decreased in garlic-fed rats which could be due to a direct antioxidant effect of garlic. This may be the initial event in the garlic-fed rats that leads to the decreased CAT expression. Our data strongly suggest that the diminished renal and hepatic CAT expression in garlic-fed rats is mediated by post-transcriptional changes (mainly low translational efficiency) which could be an adaptation to the low H2O2.


Assuntos
Catalase/biossíntese , Alho/uso terapêutico , Regulação Enzimológica da Expressão Gênica , Fitoterapia , Plantas Medicinais , Processamento Pós-Transcricional do RNA , Amitrol (Herbicida)/farmacologia , Animais , Antioxidantes/metabolismo , Northern Blotting , Western Blotting , Peso Corporal/efeitos dos fármacos , Creatinina/urina , Comportamento Alimentar/efeitos dos fármacos , Glutationa Peroxidase/biossíntese , Glutationa Peroxidase/sangue , Peróxido de Hidrogênio/metabolismo , Rim/metabolismo , Cinética , Peróxidos Lipídicos/metabolismo , Fígado/metabolismo , Masculino , Biossíntese de Proteínas , RNA/metabolismo , RNA Mensageiro/metabolismo , RNA Ribossômico 18S/metabolismo , Ratos , Ratos Wistar , Espectrofotometria , Superóxido Dismutase/biossíntese , Superóxido Dismutase/sangue , Fatores de Tempo
7.
Free Radic Biol Med ; 29(7): 602-11, 2000 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-11033412

RESUMO

Reactive oxygen species are involved in gentamicin (GM) nephrotoxicity, and garlic is effective in preventing or ameliorating oxidative stress. Therefore, the effect of garlic on GM nephrotoxicity was investigated in this work. Four groups of rats were studied: (i) fed normal diet (CT), (ii) treated with GM (GM), (iii) fed 2% garlic diet (GA), and (iv) treated with GM and 2% garlic diet (GM + GA). Rats were placed in metabolic cages and GM nephrotoxicity was induced by injections of GM (75 mg/kg every 12 h) for 6 d. Lipoperoxidation and enzyme determinations were made in renal cortex on day 7. GM nephrotoxicity was made evident on day 7 by (i) tubular histological damage, (ii) enhanced BUN and urinary excretion of N-acetyl-beta-D-glucosaminidase, and (iii) decreased creatinine clearance. These alterations were prevented or ameliorated in GM + GA group. The rise in lipoperoxidation and the decrease in Mn-SOD and glutathione peroxidase (GPx) activities observed in the GM group, were prevented in the GM + GA group. Cu, Zn-SOD activity and Mn-SOD and Cu,Zn-SOD content did not change. CAT activity and content decreased in the GM, GA, and GM + GA groups. CAT mRNA levels decreased in the GM group. The protective effect of garlic is associated with the prevention of the decrease of Mn-SOD and GPx activities and with the rise of lipoperoxidation in renal cortex.


Assuntos
Catalase/metabolismo , Alho , Gentamicinas/toxicidade , Glutationa Peroxidase/metabolismo , Rim/efeitos dos fármacos , Rim/enzimologia , Peroxidação de Lipídeos/efeitos dos fármacos , Plantas Medicinais , Superóxido Dismutase/genética , Acetilglucosaminidase/urina , Animais , Nitrogênio da Ureia Sanguínea , Catalase/genética , Dieta , Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Rim/patologia , Córtex Renal/efeitos dos fármacos , Córtex Renal/patologia , Masculino , Estresse Oxidativo , Proteinúria , Ratos , Ratos Wistar , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Superóxido Dismutase/metabolismo
8.
Mol Cell Biochem ; 211(1-2): 69-77, 2000 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-11055549

RESUMO

Nephrotic syndrome (NS) is characterized by proteinuria, oxidative stress and endogenous hyperlipidemia. Hyperlipidemia and oxidative stress may be involved in coronary heart disease and the progression of renal damage in these patients. Garlic has been suggested to be beneficial in various disease states. Some of the beneficial effects of garlic may be secondary to its hypolipidemic and antioxidant properties. Therefore, the effect of a 2% garlic diet on acute and chronic experimental NS induced by puromycin aminonucleoside (PAN) was studied in this work. Acute NS was induced by a single injection of PAN to rats which were sacrificed 10 days later. Chronic NS was induced by repeated injections of PAN to rats which were sacrificed 84 days after the first injection. Garlic treatment was unable to modify proteinuria in either acute or chronic NS, and hypercholesterolemia and hypertriglyceridemia in acute NS. However, garlic treatment diminished significantly total-cholesterol, LDL-cholesterol and triglycerides, but not HDL-cholesterol in chronic NS. Garlic induced no change in the percentage of sclerotic glomeruli in chronic NS and a significative decrease on the percentage of sclerotic area of these glomeruli (33 +/- 3% in NS+Garlic group vs. 47 +/- 4% in NS group, p = 0.0126). The enhanced in vivo renal H2O2 production and the diminished renal Cu, Zn-SOD and catalase activities in acute NS, and the decreased renal catalase activity in chronic NS were not prevented by garlic treatment. These data indicate that garlic treatment ameliorates hyperlipidemia and renal damage in chronic NS which is unrelated to proteinuria or antioxidant enzymes.


Assuntos
Alho/uso terapêutico , Hiperlipidemias/terapia , Hipolipemiantes/uso terapêutico , Síndrome Nefrótica/terapia , Fitoterapia , Plantas Medicinais , Puromicina Aminonucleosídeo/administração & dosagem , Animais , Catalase/metabolismo , Colesterol/sangue , HDL-Colesterol/sangue , LDL-Colesterol/sangue , Doença Crônica/terapia , Modelos Animais de Doenças , Glutationa Peroxidase/sangue , Glutationa Peroxidase/metabolismo , Peróxido de Hidrogênio/metabolismo , Hiperlipidemias/induzido quimicamente , Hipolipemiantes/farmacologia , Rim/efeitos dos fármacos , Rim/enzimologia , Rim/metabolismo , Rim/patologia , Masculino , Síndrome Nefrótica/induzido quimicamente , Síndrome Nefrótica/fisiopatologia , Proteinúria/metabolismo , Puromicina Aminonucleosídeo/toxicidade , Ratos , Ratos Wistar , Superóxido Dismutase/metabolismo , Triglicerídeos/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA